Concepedia

Xiaoli Xu

XX

17

Publications

655

Citations

13

H-Index

2011

Active since

Affiliations

Shanghai Cancer Institute(Current)

Shanghai Jiao Tong University

Renji Hospital

Southern Medical University

General Hospital of Central Theater Command

Xiaoli Xu is an author at Shanghai Cancer Institute specializing in medicine, cell biology, and inflammation.

ORCID

Top concepts

Publications per year

2011–2024

17

Publications

17

USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis

Aihui Ma, Ming Tang, Li Zhang et al. · Oncogene · 2018 · 120 citations

, , +5

Myeloid-derived growth factor inhibits inflammation and alleviates endothelial injury and atherosclerosis in mice

Biying Meng, Yixiang Li, Yan Ding et al. · Science Advances · 2021 · 88 citations · Full text

, , +19

RETRACTED ARTICLE: Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice

Lingfeng Shi, Yixiang Li, Xiaoli Xu et al. · Nature Metabolism · 2022 · 81 citations · Full text

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade

Zhaojuan Yang, Guiqin Xu, Boshi Wang et al. · Nature Communications · 2021 · 75 citations · Full text

POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity

Li Zhang, Yun Liu, Boshi Wang et al. · Nature Communications · 2018 · 45 citations · Full text

Rows per page

1–5 of 17